Marta Rapado‐Castro

ORCID: 0000-0001-8484-6051
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Schizophrenia research and treatment
  • Bipolar Disorder and Treatment
  • Child and Adolescent Psychosocial and Emotional Development
  • Functional Brain Connectivity Studies
  • Tryptophan and brain disorders
  • Attention Deficit Hyperactivity Disorder
  • Child Abuse and Trauma
  • Stress Responses and Cortisol
  • Cannabis and Cannabinoid Research
  • Mental Health and Psychiatry
  • Autism Spectrum Disorder Research
  • Genetics and Neurodevelopmental Disorders
  • Obsessive-Compulsive Spectrum Disorders
  • Neuroscience and Neuropharmacology Research
  • Treatment of Major Depression
  • Amino Acid Enzymes and Metabolism
  • Neurological disorders and treatments
  • Mental Health Treatment and Access
  • Diet and metabolism studies
  • Liver Disease and Transplantation
  • Child and Adolescent Health
  • Genetic Associations and Epidemiology
  • Mental Health Research Topics
  • Health Systems, Economic Evaluations, Quality of Life
  • Hepatitis C virus research

Instituto de Salud Carlos III
2014-2025

Centro de Investigación Biomédica en Red de Salud Mental
2015-2025

Hospital General Universitario Gregorio Marañón
2015-2025

The University of Melbourne
2015-2025

Melbourne Health
2014-2024

Universidad Complutense de Madrid
2014-2024

Centre for Biomedical Network Research on Rare Diseases
2022-2024

University of Bologna
2023

Hospital Clínico San Carlos
2023

Instituto de Investigación Sanitaria del Hospital Clínico San Carlos
2023

Marta Di Forti Diego Quattrone Tom P. Freeman Giada Tripoli Charlotte Gayer‐Anderson and 82 more Harriet Quigley Victoria Rodríguez Hannah E. Jongsma Laura Ferraro Caterina La Cascia Daniele La Barbera Ilaria Tarricone Domenico Berardi Andreı̈ Szöke Celso Arango Andrea Tortelli Eva Velthorst Miquel Bernardo Cristina Marta Del‐Ben Paulo Rossi Menezes Jean-Paul Selten Peter B. Jones James B. Kirkbride Bart P. F. Rutten Lieuwe de Haan Pak C. Sham Jim van Os Cathryn M. Lewis Michael T. Lynskey Craig Morgan Robin M. Murray Sílvia Amoretti Manuel Arrojo Grégoire Baudin Stephanie Beards Miquel Bernardo Julio Bobes Chiara Bonetto Bibiana Cabrera Ángel Carracedo Thomas Charpeaud Javier Costas Doriana Cristofalo Pedro Cuadrado Covadonga M. Díaz‐Caneja Aziz Ferchiou Nathalie Franke Flora Frijda Enrique García Bernardo María Paz García‐Portilla Emiliano González Kathryn Hubbard Stéphane Jamain Estela Jiménez‐López Marion Leboyer Gonzalo López Montoya Esther Lorente-Rovira Camila Marcelino Loureiro Giovanna Marrazzo Covadonga M. Díaz‐Caneja Mario De Matteis Elles Messchaart Ma Dolores Moltó Juan Nácher Ma Soledad Olmeda Mara Parellada Javier González‐Peñas Baptiste Pignon Marta Rapado‐Castro Jean‐Romain Richard José Juan Rodríguez Solano Laura Roldán Díaz Mirella Ruggeri Pilar A. Sáiz Emilio Sánchez Julio Sanjuán Crocettarachele Sartorio Franck Schürhoff Fabio Seminerio Rosana Shuhama Lucia Sideli Simona A. Stilo Fabian Termorshuizen Sarah Tosato Anne-Marie Tronche Daniella van Dam E. van der Ven

Cannabis use is associated with increased risk of later psychotic disorder but whether it affects incidence the remains unclear. We aimed to identify patterns cannabis strongest effect on odds across Europe and explore differences in such contribute variations rates disorder.

10.1016/s2215-0366(19)30048-3 article EN cc-by The Lancet Psychiatry 2019-03-19

OBJECTIVE The authors sought to assess the efficacy of functional remediation, a novel intervention program, on improvement in sample euthymic patients with bipolar disorder. METHOD In multicenter, randomized, rater-blind clinical trial involving 239 outpatients DSM-IV disorder, remediation (N=77) was compared psychoeducation (N=82) and treatment as usual (N=80) over 21 weeks. Pharmacological kept stable all three groups. primary outcome measure global psychosocial functioning, measured...

10.1176/appi.ajp.2012.12070971 article EN American Journal of Psychiatry 2013-03-20

Background/Objectives: Decompensated cirrhosis is characterized by systemic inflammation and innate adaptive immune dysfunction. Hepatic encephalopathy (HE) a prevalent debilitating condition cognitive disturbances in which ammonia play synergistic pathogenic role. Extraskeletal functions of vitamin D include immunomodulation, its deficiency has been implicated dysfunction different forms impairment. The aim was to assess changes function decompensated patients with receiving...

10.3390/nu17020226 article EN Nutrients 2025-01-09

Background/Objective: The heterogeneous clinical presentations of individuals with Autism Spectrum Disorders (ASD) pose a significant challenge for sample characterization. Therefore the main goal DSM-5 must be to identify subgroups ASD, including comorbidity disorders and severity. this study is explore psychiatric comorbidities severity symptoms that could relevant phenotype characterization in ASD also compare these results according different classification criteria between DSM-IV-TR...

10.1016/j.ijchp.2016.03.001 article ES cc-by-nc-nd International Journal of Clinical and Health Psychology 2016-06-04

Background Cognitive deficits are predictors of functional outcome in patients with psychosis. While conventional antipsychotics relatively effective on positive symptoms, their impact negative and cognitive symptoms is limited. Recent studies have established a link between oxidative stress neurocognitive N -acetylcysteine (NAC), glutathione precursor glutamatergic properties, has shown efficacy functioning schizophrenia bipolar disorder, respectively. However, there few evidence-based...

10.1017/s0033291716002932 article EN Psychological Medicine 2016-11-29

Increasing evidence supports the important role of illness state and individual characteristics in insight.Insight, as measured with Scale to Assess Unawareness Mental Disorder, over first 2 years early-onset first-episode psychosis its correlations clinical, socio-demographic, cognitive, structural brain variables are studied.(1) insight at is poorer schizophrenia spectrum disorders (SSDs) than subjects other psychoses; (2) more severe psychosis, worse insight. In SSD, depressive symptoms,...

10.1093/schbul/sbq109 article EN Schizophrenia Bulletin 2010-09-30

Background The longitudinal neuropsychological study of first-episode early-onset psychosis (EOP) patients, whose brain maturation is still in progress at the time illness onset, provides a unique opportunity to compare their cognitive development with that healthy subjects, search specific patterns resulting from interaction between neurodevelopmental processes and presence psychotic disorders. Method Seventy-five EOP patients (schizophrenia n = 35; bipolar disorder 17; other forms 23) mean...

10.1017/s0033291712001535 article EN Psychological Medicine 2012-07-25

Tobacco use in mental health general and bipolar disorder particular remains disproportionally common, despite declining smoking rates the community. Furthermore, interactions between tobacco have been shown, indicating outcomes for those with disorders are impacted by use. Factors need to be explored addressed improve these target specific interventions people psychiatric illness cease smoking. In context of disorder, this review explores; effects on symptoms, quality life, suicidal...

10.9758/cpn.2015.13.1.1 article EN Clinical Psychopharmacology and Neuroscience 2015-04-23

This study investigates the impact of childhood maltreatment (CM) on hypothalamic-pituitary-adrenal (HPA)-axis functioning and anxiety perception. Moreover, influence CM severity frequency was also explored.In total, 187 participants aged 7-17 were assessed for history using validated questionnaires ad hoc interviews to be classified according criteria Tool Assessing Severity Situations in which Children are Vulnerable (TASSCV). Psychopathology ascertained K-SADS-PL5. To assess HPA-axis...

10.1017/s003329172100249x article EN cc-by Psychological Medicine 2021-07-16

Background/aim: Frailty is increasingly recognized as a relevant prognostic factor in patients with cirrhosis, regardless of liver failure. Vitamin D deficiency frequent these and has been related to frailty sarcopenia, but the impact its supplementation on cirrhosis unknown. The aim was evaluate effect vitamin decompensated or insufficiency. Methods: We included who had insufficiency following their hospitalization for acute decompensation. supplemented according current recommendations,...

10.3390/medsci13010030 article EN cc-by Medical Sciences 2025-03-13

The objective of the study is to examine association baseline total antioxidant status (TAS) and glutathione (GSH) levels with short- long-term cognitive functioning in patients early onset first-episode psychosis, comparing affective non-affective psychoses. We analysed 105 an onset-first episode psychosis (age 9-17 years) 97 healthy controls. Blood samples were taken at admission for measurement TAS GSH, performance was assessed 2years follow-up. Regression analysis used assess...

10.1016/j.schres.2014.03.025 article EN cc-by-nc-nd Schizophrenia Research 2014-04-24

Background: In recent decades, the assessment of neurological soft signs (NSS) in patients with psychosis has become a subject special interest. The study progression NSS during adolescence will provide valuable information about role as endophenotypes or biomarkers and brain development at stage which maturation not yet been completed. Methods: Neurological were assessed sample 110 first episodes early‐onset (EOP) 98 healthy children adolescents two different times 2‐year follow‐up period....

10.1111/j.1469-7610.2011.02475.x article EN Journal of Child Psychology and Psychiatry 2011-10-25
Diego Quattrone Ulrich Reininghaus Alexander Richards Giada Tripoli Laura Ferraro and 89 more Andrea Quattrone Paolo Marino Victoria Rodríguez Edoardo Spinazzola Charlotte Gayer‐Anderson Hannah E. Jongsma Peter B. Jones Caterina La Cascia Daniele La Barbera Ilaria Tarricone Elena Bonora Sarah Tosato Antonio Lasalvia Andreı̈ Szöke Celso Arango Miquel Bernardo Julio Bobes Cristina Marta Del‐Ben Paulo Rossi Menezes Pierre‐Michel Llorca José Luis Santos Julio Sanjuán Manuel Arrojo Andrea Tortelli Eva Velthorst Steven Berendsen Lieuwe de Haan Bart P. F. Rutten Michael T. Lynskey Tom P. Freeman James B. Kirkbride Pak C. Sham Michael O’Donovan Alastair G. Cardno Evangelos Vassos Jim van Os Craig Morgan Robin M. Murray Cathryn M. Lewis Marta Di Forti Kathryn Hubbard Stephanie Beards Simona A. Stilo Mara Parellada David Fraguas Marta Rapado‐Castro Álvaro Andreu-Bernabeu Gonzalo López Mario De Matteis Emiliano González Manuel Durán-Cutilla Covadonga M. Díaz‐Caneja Pedro Cuadrado José Juan Rodríguez Solano Ángel Carracedo Javier Costas Emilio Sánchez Sílvia Amoretti Esther Lorente-Rovira María Paz García‐Portilla Estela Jiménez‐López Nathalie Franke Daniella van Dam Fabian Termorshuizen Nathalie Franke E. van der Ven Elles Messchaart Marion Leboyer Franck Schürhoff Stéphane Jamain Grégoire Baudin Aziz Ferchiou Baptiste Pignon Jean‐Romain Richard Thomas Charpeaud Anne-Marie Tronche Flora Frijda Giovanna Marrazzo Lucia Sideli Crocettarachele Sartorio Fabio Seminerio Camila Marcelino Loureiro Rosana Shuhama Mirella Ruggeri Chiara Bonetto Doriana Cristofalo Domenico Berardi Marco Seri Giuseppe D’Andrea

Abstract Diagnostic categories do not completely reflect the heterogeneous expression of psychosis. Using data from EU-GEI study, we evaluated impact schizophrenia polygenic risk score (SZ-PRS) and patterns cannabis use on transdiagnostic We analysed first-episode psychosis patients (FEP) controls, generating dimensions psychotic symptoms experiences using item response bi-factor modelling. Linear regression was used to test associations between these SZ-PRS, as well combined effect SZ-PRS...

10.1038/s41398-021-01526-0 article EN cc-by Translational Psychiatry 2021-08-10

To investigate the relationship between cognition and prior cannabis use in children adolescents presenting a first episode of psychosis. A total 107 patients with psychosis 96 healthy controls, aged 9 to 17 years, were interviewed about their previous substance assess cognitive functions. Patients assessed while not using by means comprehensive neuropsychological battery. They divided into 2 groups depending on history use: users (CU) nonusers (CNU). Significant differences found all areas...

10.1097/nmd.0b013e3181cc0d41 article EN The Journal of Nervous and Mental Disease 2010-02-01
Coming Soon ...